Anna Sablina is a group leader at the VIB Center for Cancer Biology and an associate professor at the University of Leuven. Dr. Sablina was trained as master in Biochemistry at the Moscow State University and obtained her PhD in 2002 in Molecular Oncology at the Cancer Research Center in Moscow. After her PhD, Dr. Sablina moved to the US where she completed her postdoctoral training at the Cleveland Clinic Foundation and at the Dana Farber Cancer Institute. In 2009, Dr. Sablina started as a group leader at VIB and a professor position at the University of Leuven. Since the start of her career as an independent researcher, Dr. Sablina received several prizes, including the Swiss Bridge Award and the EMBO Young Investigator Award. She is a holder of ERC Starting Grant (2011) and ERC Consolidator Grant (2018).
The focus of Anna Sablina’s laboratory is to elucidate the role of ubiquitin system in human disease. To achieve this, she has been taking a multi-faceted approach; combining mouse modelling techniques with comprehensive biochemical and genetics studies.